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Follicleccurs during oocyte growth in mice, a stage where a number of important events
are occurring, including transcription of maternal mRNAs for storage in the mature egg, global transcriptional
silencing and the acquisition of meiotic competence. Oocyte growth occurs in conjunction with follicular
development over a period of many days. The signals involved in initiating different stages in oocyte and
follicular development and the concurrent epigenetic changes are poorly understood. Here we examine the
role of stem cell factor (SCF or Kit ligand) on the early- to mid-stages of oocyte growth and on DNA
methyltransferase expression and function using a one-step in vitro culture system. Our results show that
SCF promotes early oocyte growth and development to the multilaminar follicle stage. Oocyte growth is
sufﬁcient to trigger transcription of Dnmt1 and Dnmt3L from dedicated oocyte promoters, and we show that
eggs undergoing growth in the absence of follicle development in Foxo3 mutants show elevated levels of
Dnmt1. The methyltransferase proteins undergo sequential relocalisation in the oocyte, with DNMT1 being
exported from the nucleus at the bilaminar follicle stage, while DNMT3A is transported into the nucleus at
the multilaminar stage, indicating an important role for trafﬁcking in controlling imprinting. SCF is thought
to signal partly through the phophostidylinositol 3 (PI3) kinase pathway: inhibiting this path was previously
shown to prevent FOXO3 nuclear export and we could show here that it also prevented DNMT1 export. Some
oocytes reached full size (70 μM) in this in vitro system, but no secondary follicles were formed, most likely
due to failure of the thecal layer to form properly. De novo methylation of imprinted genes was seen in some
oocyte cultures, with methylation levels being highest for Snrpn and Igf2rwhich are methylated early in vivo,
while Peg1, which is methylated late, showed little or no methylation. SCF treatment did not increase the
number of cultures showing methylation. We saw no evidence for de novo methylation of IAP repeats in our
cultures. These results suggest that while methyltransferase loading is triggered by oocyte growth, in which
SCF plays an important role, complete methylation probably requires progression to the secondary follicle
stage and is unlikely to be affected by SCF.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe germ cells become segregated from other lineages early in
development and migrate into the developing gonad, where they
differentiate in close association with somatic cells. Female germ cells
in mice enter meiosis after arrival at the presumptive ovary and
progress to the diplotene stage of prophase I, where they arrest. At this
stage each oocyte becomes surrounded by a ring of squamous somatic
cells called granulosa cells, to form a functional unit called the
primordial follicle (see van den Hurk and Zhao, 2005 for a recent
review). Most follicles will remain at this stage throughout the life of
the female, but periodically, some will become committed to further
development (Fig. 1A). These make the transit to the primary folliclel rights reserved.stage, characterised by a squamous to cuboidal transition in the
granulosa cells, together with an increase in oocyte volume and the
activation of gene transcription (Schultz et al., 1979). The granulosa
cells proliferate to form a number of layers and the oocyte lays down
the zona pellucida. Cells on the outside of the follicle form a squamous
thecal layer, which becomes inﬁltrated with capillaries (Hirshﬁeld,
1991). As this stage, a ﬂuid-ﬁlled antrum or vesicle starts to form and
the follicle is now known as a secondary follicle. During these stages,
the oocyte continues to grow until reaching its maximum size (about
70 μm, not including the zona pellucida) and the nucleus undergoes
changes to make it competent to resume meiosis (Mattson and
Albertini, 1990). Antral follicles become responsive to endocrine
factors, in particular follicle-stimulating hormone, which recruit them
for further growth. Mature secondary follicles are responsive to
luteinising hormone, which trigger resumption of meiosis and
ovulation (van den Hurk and Zhao, 2005).
Fig. 1. Summary of oocyte growth and folliculogenesis. Oocyte and follicle development are indicated, along with the changes seen in oocyte chromatin staining (Mattson and
Albertini, 1990). Oocyte and follicle size ranges at each stage are indicated at the bottom. As they complete prophase of meiosis I and enter diplotene (dictyate arrest), oocytes become
surrounded by a single layer of squamous granulosa cells in what is called the primordial follicle (A). Unilaminar primary follicles are characterized by a single layer of cuboidal
granulosa cells and increased oocyte size (B). Multilaminar primary follicles have several granulosa cell layers and a ZP surrounding the oocyte, which often has a prominent
nucleolus (C). Secondary follicles are surrounded by a layer of squamous thecal cells and develop a ﬂuid-ﬁlled antrum (D and E). The chromatin becomes increasingly condensed
around the nucleolus to form a ring.
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embryogenesis, since this is the stage at which gene transcription
occurs (Wassarman and Kinloch, 1992). The mRNA produced are
required for oocyte metabolism or development or as maternal factors
important for the early development of the embryo itself. Oocyte
growth is also an important time for establishing epigenetic marks on
the female genome. The majority of imprinted genes appear to be
controlled by methylation of the DNA on their imprint control regions
(ICR) in the female germ cells (Reik and Walter, 2001). Methylation
marks are removed in the primordial germ cells and de novo
methylation occurs in a speciﬁc sequence during oocyte growth (see
Lees-Murdock and Walsh, 2007 for a recent review). Of the two de
novo methyltransferases, disruption of the catalytic site of DNMT3A
has been shown to abrogate ICR methylation in the egg, with
subsequent failure of embryogenesis due to aberrant expression of
imprinted genes, whereas DNMT3B disruption has been reported as
having no effect (Kaneda et al., 2004). The other factor crucial for de
novo methylation is the protein DNMT3L, since in its absence
DNMT3A alone is unable to establish imprints (Bourc'his et al.,
2001). The remaining DNAmethyltransferase DNMT1 has been shown
to be dispensable for imprint establishment in the egg, but is required
as a maternal factor in early embryogenesis for imprint maintenance
(Howell et al., 2001). Genetic studies have suggested however that
DNMT1 may play a role in methylation of repeat elements such as
intracisternal A particles (IAP) in the growing oocytes (Gaudet et al.,
2004).
Factors inﬂuencing primary follicle recruitment and oocyte growth
are not completely understood, but a number of signalling molecules
have been implicated as playing a possible role (for a review see van
den Hurk and Zhao, 2005). One candidate is stem cell factor (SCF), also
known as kit ligand (KL), which maps to the Steel locus. Many mutant
alleles of Steel result in mice with almost no germ cells, indicating a
role in primordial germ cell survival, but there are also hypomorphic
alleles (KitlSl-con, KitlSl-t, KitlSl-pan) showing defects at the primary
follicle stage instead (Bedell et al., 1995; Huang et al., 1993; Kuroda et
al., 1988). Supplementing in vitro cultures with SCF can stimulategrowth of the oocytes, which express the receptor c-kit (Klinger and
De Felici, 2002). Leukemia inhibitory factor (LIF) is also known to
promote survival, proliferation and initiation of meiosis in germ cells
and is produced by granulosa cells (Nilsson et al., 2002). Bone
morphogenetic protein 4 (BMP-4) has likewise been shown to have a
positive effect on PGC survival and differentiation and is produced by
thecal cells (Lee et al., 2001).
In the present study, we wished to look more closely at what stage
(s) of oocyte growth DNA methyltransferase expression occurred and
imprints were established and what developmental signals might
trigger these events. To do so, we developed a technique based on
earlier work (McLaren and Buehr, 1990; Pesce et al., 1996), whereby
fragments of fetal ovary tissue are explanted and grown in vitro. Here
we characterise oocyte growth in this system compared to in vivo and
examine the expression, localisation and activity of the DNA
methyltransferases together with methylation of a number of
imprinted genes and IAP elements. Our results indicate that the
signals triggering oocyte growth and DNA methyltransferase expres-
sion are separate from those required for imprinting, with the former
being triggered solely by oocyte growth and the latter likely requiring
progression to the antral follicle stage.
Results
Oocyte growth in vitro
In order to obtain growing oocytes in vitro, we dissected e15.5
embryonic ovaries away from their surrounding tissue, before
dividing each ovary into 4–5 fragments. These were then plated
onto ﬁbronectin-coated tissue culture dishes or glass slides and
cultured in Waymouth medium containing serum (see Materials and
methods and Fig. 2A) for up to three weeks. By day 7 of culture
growing oocytes could be distinguished due to their size and the
recruitment of rings of granulosa cells (Fig. 2B). By week 2 of culture,
the germinal vesicle could also be distinguished. Growing oocytes
continued to increase in size until week three of culture (Fig. 2B),
Fig. 2. Oocyte growth and development in vitro. (A) Experimental strategy. Mouse ovaries were harvested at e15.5, dissected away from the mesonephros, cut into fragments and
plated. Fragmentswere growncontinuously in culturewith various growth factors for 21 days and oocytes harvested as described before analysis. (B) Appearance of growing oocytes in
vitro. (a) A low-power view of the ovary fragment explant after 7 days (d7) shows that large cells with oocyte morphology have started to appear in the middle of each ﬂattened
fragment. (b) A higher power view of a, showing some evidence of rings of somatic cells around the oocytes (arrowheads). (c) d14, with further oocyte growth and granulosa cell
proliferation. (d) Byweek three (d21), no further growth of oocytes is seen, though some can be seen to contain the distinctive germinal vesicle (GV— arrows). (C) Oocytes isolated from
culture. (a) Most oocytes isolated from d21 cultures showed the presence of a zona pellucida (ZP) and GV. (b) Tight association of granulosa cells (gc) with the oocytes was evident.
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longer periods did not result in further growth. Many oocytes
isolated from week 3 cultures by trituration could be seen to have a
distinct zona pellucida and germinal vesicle in the nucleus (Fig. 2C).
The surrounding granulosa cells have formed rings and many appear
to be attached to the oocyte through cyoplasmic bridges (Fig. 2C), as
they could not be removed by trituration or mild enzymatic
digestion.
Examination of propidium iodide-stained slides also illustrates
several other important features of the in vitro system. Recruitment
of primordial follicles to primary is marked by the transition of
granulosa cells surrounding the oocyte from squamous to cuboidal
in shape (Fig. 3A). This is followed by recruitment of a second layer
of follicle cells, until by d21 there are three or more layers of cells
surrounding the larger oocytes. However, recruitment of a contig-
uous thecal cell layer and production of an antrum, characteristic of
secondary follicles, was not observed in our cultures. No squamous
cell layer surrounding the granulosa cells was seen. Staining for
alkaline phosphatase, present at high levels in thecal cells
(Cortvrindt et al., 1998), shows the presence of a distinct layer of
squamous AP-positive cells around secondary oocytes from 17 days
post-partum (dpp) ovaries. Staining of in vitro explants shows that
thecal precursors are present, but that they fail to form a complete
ring structure (Fig. 3B). Hoescht staining of the nuclei also shows
that the oocyte nuclei do not reach the stage characteristic of the
fully grown oocyte (Stage IV in Mattson and Albertini, 1990: see Fig.
1): most oocytes were at Stage II (Fig. 3C).
Effect of growth factor supplementation on early oocyte growth
SCF and BMP-4 have both been suggested to stimulate oocyte
growth and promote survival (Klinger and De Felici, 2002; Lee et
al., 2001) and LIF is a potent survival factor for ES cells and other
pluripotential populations (Nilsson et al., 2002). We tested theeffects of these factors on oocyte growth in our in vitro system by
supplementing the medium. Fig. 4A shows the overall effects of the
growth factors: it can be seen that in the ﬁrst week, the addition
of SCF or BMP-4 promotes oocyte growth and eggs in these
cultures were signiﬁcantly larger than in the controls. The addition
of LIF did not affect the oocyte size at this stage. By week 2, the
effects of SCF were even more pronounced (pb0.01) and exceeded
the effects seen by addition of BMP-4. At this stage, a positive
effect of LIF was also apparent. By the end of week three, none of
the growth factor-supplemented cultures showed an increased
oocyte size relative to controls (LIF in fact showing a small negative
effect), suggesting that there is no further beneﬁt to the oocytes
after week 2 and that the controls have caught up with those
cultures receiving supplements.
The effects of SCF are even more apparent if oocytes are split into
size classes (Fig. 4B) and compared to controls. At day 7, most oocytes
are relatively small (16–25 μM in diameter) but SCF supplementation
results in a substantial increase in the number of oocytes in the 26–
35 μMclass and the appearance of some in the 36–45 μMclass. On d14,
a skewing of oocyte size to the larger size categories is again apparent,
and this effect persists to d21.
Expression of markers for growth and maturation
We compared transcription of markers for oocyte growth between
the in vitro culture system (d7, d14 and d21) and matched in vivo
controls (3 dpp, 10 dpp and 17 dpp) and also looked at the effects of
SCF on marker expression. Growing oocytes lay down a proteinaceous
shell outside the cell membrane, the zona pellucida. This is comprised
of three proteins, termed ZP1, 2 and 3 and the genes for these proteins
are only actively transcribed in the growing oocyte (Epifano et al.,
1995). Reverse transcriptase-PCR (RT-PCR) analysis of total RNA from
the oocyte cultures showed the presence of transcripts for all three ZP
proteins from d7 onwards (Fig. 5A). For ZP2 and ZP3, transcript levels
Fig. 3. Characterisation of the stages of follicular development in vitro. (A) Granulosa cell development in vitro. (a) Propidium iodide staining and confocal analysis showed rings of
granulosa cells (gc) around the oocytes at d7. Oocyte growth had commenced and the granulosa cells were mostly cuboidal in appearance (arrow), indicating primary unilaminar
follicles. (b) Follicles appeared predominantly bilaminar at d14. (c) By d21, follicles were multilaminar but showed no evidence of antrum formation. (B) Thecal layer staining in vivo
and in vitro. (a) Alkaline phosphatase (AP) labeling shows the presence of a ring of thecal cells (red) around the secondary follicles in sections taken from 17 dpp in vivo. Small blood
vessels outside the follicles are also visible. (b) AP staining shows the presence of thecal cell precursors in vitro. Some are clumped around the larger oocytes (one visible in centre),
but fail to form complete rings. (C) Oocyte chromatin condensation is incomplete. Staining with Hoescht showed that oocytes reached stages I (a) and II (b) but none achieved full
maturation (stage IV), characterized by the appearance of a surrounded nucleolus. Scale bars 50 μM.
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increasing signal in the in vitro cultures as well, from d7 to day 21. In
the presence of SCF, an increased level of ZP RT-PCR products were
detected, but this was not signiﬁcantly different when assayed by
quantitative PCR (qPCR— Fig. 5C). To verify the presence of the zona,
we stained cultures with wheat germ agglutinin, a lectin which
detects post-translational glycosylation of the ZP proteins (Kapur and
Johnson, 1985), and found positive staining of the larger in vitro
cultured oocytes (Fig. 5B).
Oocytes at e15.5 are at the zygotene/pachytene stage of prophase
and progress in vivo to the diplotene stage, where they undergo
meiotic arrest. We examined transcription of synaptonemal complex
protein 3 (Sycp3), which could be seen to decrease in vivo from 3 dpp
to 17 dpp, when it is almost undetectable, indicating the completion of
entry into diplotene stage of the primary oocytes (Fig. 5D). A similar
pattern is seen in vitro, where Sycp3 levels decrease from d7 to d21.
Cultures with SCF added show increased levels of Sycp3 transcript at
all stages. Similarly Mouse vasa homologue (MVH; also known as
DDX4) is a marker for fetal oocytes and absent from somatic cells. It is
also localised to the cytoplasm of early growing oocytes but absent
from oocytes in antral stage follicles (Toyooka et al., 2000). It can be
seen from Fig. 5D that Mvh transcription is also decreasing in vivo as
the ﬁrst wave of growing oocytes matures. This is paralleled by the in
vivo culture. SCF-treated cultures show increased MVH signal by RT-
PCR, which is most apparent at d21.
We could also verify the presence of thecal cell markers in the
oocyte cultures. RT-PCR for Cytochrome P450 17αHydroxylase/17,20
lyase (Cyp17a1) and Luteinising hormone/choriogonadotropin recep-
tor (Lhcgr) (Elvin et al., 1999) were both positive from in vitro grown
cultures (Fig. 5E), conﬁrming the presence of thecal cells as indicated
by the AP staining, although the Cyp17a1was noticeably weaker in the
in vitro culture. Failure to recruit thecal cells to form a layer around the
oocyte has previously been observed in Gdf9 knockout mice (Elvin et
al., 1999): however, mRNA for this oocyte-speciﬁc marker is also
present in the in vitro grown cultures (Fig. 5E).Transcription and localisation of DNA methyltransferases
We examined transcription of Dnmt1o and Dnmt3Lo, both of which
are exclusively produced by growing oocytes and not in somatic cells
(Mertineit et al., 1998; Shovlin et al., 2007). The mRNA for these two
transcripts is present at low levels at 3 dpp in vivo (Fig. 6A), but
transcripts accumulate to high levels by 17 dpp, in accordance with
data from previous studies. In vitro, a similar pattern is seen, with high
transcript levels detected from d14 onwards, when the growing
oocytes have reached an average size of 35–40 μM. Again, in the
presence of SCF an increased level of these two transcripts was
detected at d21 (Fig. 6A). To further investigate, we carried out RT-PCR
at d21 for different numbers of cycles and show that the Dnmt1o and
Dnmt3Lo transcripts appear earlier in the SCF-treated cultures (Fig.
6B): qPCR also indicated a modest increase in the level of Dnmt3Lo
transcripts at d21 in SCF-treated cultures (Fig. 6C). Likewise, treatment
with LIF or BMP4 also seemed to give increased levels of Dnmt1o, and
to a lesser extent Dnmt3Lo (Fig. 6D). These results suggest that factors
which promote primordial to primary follicle transition and oocyte
growth trigger activation of the oocyte-speciﬁc promoters for Dnmt1
and Dnmt3L. To conﬁrm that this effect is oocyte-autonomous, we
looked at Foxo3−/− ovaries, where universal primordial follicle
activation occurs in the absence of granulosa cell development
(Castrillon et al., 2003). Using microarray analysis (Gallardo et al.,
2007), we found that Dnmt1 was over-expressed in the ovaries from
Foxo3 mutants at d14, when oocytes in primordial follicles have
grown to twice the size of their WTcounterparts (Fig. 6E). This pattern
was seen with two different probes for Dnmt1, with three replicates
per timepoint and genotype.
Subcellular localisation is important in determining whether the
methyltransferases have access to their target sequences (Lees-
Murdock, 2006). We examined expression in the in vitro cultures
using antibodies to DNMT1, DNMT3A and DNMT3B (Fig. 7A) (Lees-
Murdock et al., 2005;Mertineit et al., 1998). In general, the localization
of these methyltransferases in the in vitro growing oocytes resembled
Fig. 4. Effect of growth factors on oocyte growth in vitro. (A) SCF signiﬁcantly increases
oocyte growth in vitro. Stem cell factor (SCF), Leukemia inhibitory factor (LIF) and Bone
morphogenetic protein 4 (BMP-4) were added to the culture medium after plating and
throughout the culture period. Oocyte diameter was measured using an ocular
micrometer. (B) Oocyte cohort growth in the presence or absence of SCF. In the
presence of the growth factor, oocytes reached larger size categories earlier than their
control counterparts inweeks 1 and 2. By week three, the growth advantage disappears
(d21). Note also the disappearance of oocytes from smaller size categories, indicating
that a single cohort of oocytes is recruited to grow. The total number of oocytes counted
from two independent experiments is indicated in brackets; ⁎pb0.05 and ⁎⁎pb0.01
compared to control oocytes at same time point (A) and in the same category (B).
242 D.J. Lees-Murdock et al. / Developmental Biology 321 (2008) 238–250that described in vivo, but visualisation was considerably clearer and
the coordinate growth of a cohort of oocytes meant that events
appeared to occur in near synchrony in adjacent oocytes. Dnmt1 gives
strong signal localised to the nucleus of oocytes on d7 of culture (Fig.
7A, top). By d14, the protein has been exported from the nucleus and it
is found exclusively in the cytoplasm at d21. An antibody against the
long form of Dnmt3A shows the opposite pattern: localisation at d7 is
mainly cytoplasmic in the oocyte, but on day 21 the signal appears
equally strong over both cytoplasm and nucleus (Fig. 7A). Dnmt3Bshows preferential cytoplasmic localisation at all stages examined
(Fig. 7A).
SCF is thought to signal through the phosphotidyl 3 (PI3) kinase
pathway and PI3 kinase inhibitors have been shown to block the
nuclear export of Foxo3 (Brunet et al., 1999; Reddy et al., 2005). We
treated oocyte cultures at d7 with LY294002 and examined DNMT1
localisation at d14, when the protein has normally relocated to the
cytoplasm. In the treated samples, the protein was retained in the
nucleus (Fig. 7B), suggesting that inhibition of PI3K signalling is
sufﬁcient to block export. This effect was seen in two independent
rounds of oocyte culture.
Methylation status of imprinted genes and IAP repeats
Methylation of imprinted genes occurs during the growth phase in
the female germ line (reviewed in Lees-Murdock andWalsh, 2007). To
establish whether this occurs during growth in vitro, we isolated
oocytes from d21 cultures and performed bisulﬁte modiﬁcation. This
was followed by PCR for four target genes: Snrpn, Igf2r and Peg1
which become methylated in the growing oocyte in vivo in that order,
and H19, which is methylated in sperm and unmethylated in the
oocyte and acts here as a control for contamination by somatic cells.
We carried out restriction analysis with an enzymewhich only cleaves
the PCR product if the DNA has been methylated (COBRA assay) for
three of the genes, and conﬁrmed the COBRA results by cloning and
sequencing the PCR products: for Peg1 no suitable restriction site was
available for COBRA so only the cloning and sequencing was done. The
COBRAmethod is robust for examining single-copy genes as it gives an
indication of methylation levels in the total population of cells and so
can reduce errors due to cloning bias. Table 1 summarises our results:
for many of the samples we were able to assay all four genes in
parallel, while some only yielded enough DNA to carry out PCR on 1–2
genes, in which case we assayed Snrpn and H19. Results for control
cultures 1–6 and SCF-treated cultures 1–2, which yielded enough DNA
for multiple analyses, are shown in Fig. 8A. Four control cultures (#7–
10) and four SCF-treated cultures (#3–6) yielded only enough DNA to
analyse Snrpn (in all four) and H19 (in two out of four). In no case did
we detect methylation of H19 in our samples, indicating that there
was no contamination with somatic cells (absence of methylated
bands in Fig. 8A). Snrpn showed some methylation in 2/10 control and
1/6 SCF-treated cultures by COBRA. We conﬁrmed these results by
cloning and sequencing the PCR products: results from one unmethy-
lated control (Con10) and the parallel SCF-treated sample showing
methylation by COBRA (SCF10) are shown (Fig. 8B). Three of the
control samples also showed somemethylation of Igf2r by COBRA (Fig.
8A), while sequencing showed some methylation in one additional
sample (Fig. 8C). Only one of four control cultures analysed show
methylation of Peg1, and this was conﬁned to single CpGs in each
clone (Fig. 8C). Results from bisulﬁte sequencing for all the genes
correlated well overall with the COBRA, with samples showing
methylation by COBRA having more methylated clones on sequencing
(compare control 1 and 2 in Fig. 8A with Fig. 8C): where small
differences appear between COBRA and sequenced clones, our
experience shows these to be due to sampling error in the latter.
We also examined methylation at IAP elements, a medium-copy
number selﬁsh DNA element whose transcription postnatally is
repressed by methylation (Walsh et al., 1998). As individual elements
can vary in sequence, COBRA analysis was not appropriate and only
bisulﬁte sequencing was carried out: however, cloning bias can be
excluded in this case due to the sequence heterogeneity seen, which
indicates that different copies of the element are being cloned. Fig. 8D
shows the methylation patterns observed and Fig. 8E indicates the
total methylation observed in the IAP population at the stages
examined. It can be seen that methylation is high in a population of
germ cells isolated at e16.5, which represents the methylation state of
the oocytes at the start of culture: methylation levels are essentially
Fig. 5. Expression of markers for follicular development. (A) Zona pellucida gene activation. RT-PCR analysis shows the genes for all three ZP proteins are activated in vitro. RNA from
equivalent stages in vivo (right) was used for comparison (3, 10 and 17 dpp). Levels of Zp2 and Zp3mRNA appear on average slightly higher in cultures where SCF was added. Negative
controls are shown at bottom (no RT). The sizes of the target bands are indicated by arrowheads: the ladder on the right is in 100 bp increments. (B) Staining for the presence of
mature ZP. Wheat germ agglutinin staining (arrowheads) indicates the presence of carbohydrate groups present on mature ZP proteins. Scale bar is 25 μM. (C) Quantitative PCR for
ZP3. RNAwas harvested from untreated (Ctrl) and SCF-treated (SCF) oocyte cultures at d21 and analysed for ZP3 levels using qPCR. (D) Expression of oocyte markers. Synaptonemal
protein complex 3 (Sycp3) is downregulated in vitro in parallel with in vivo as oocytes progress to diplotene. Mouse vasa homologue (Mvh) is transcribed in early growing oocytes
only, indicating progression to the late primary stage in vitro. (E) Thecal cell markers. The aromatase Cyp17a1 and Luteinising hormone/choriogonadotropin receptor (Lhcgr) are
transcribed by thecal cells in the ovary in vitro and in vivo. Growth determining factor 9 (Gdf9) is produced by the oocytes in both systems.
243D.J. Lees-Murdock et al. / Developmental Biology 321 (2008) 238–250indistinguishable at d7, and comparable at both these stages to those
seen in adult tail.
Discussion
Early oocyte growth in vitro
The factors underlying primordial to primary follicle transition and
the initiation of oocyte growth are still poorly understood, but are
likely to rely on paracrine and autocrine signalling in the gonad and be
relatively independent of endocrine signalling (van den Hurk and
Zhao, 2005). Supporting this, we found that explanting ovary
fragments at e15.5 and maintaining them in tissue culture resulted
in the transition of many primordial follicles into the primary follicle
stage with approximately the same timing as the recruitment of the
ﬁrst wave of growing oocytes in vivo. This was conﬁrmed at the
morphological level by the alteration of granulosa cell shape from
squamous to cuboidal and their parallel proliferation, an increase in
oocyte volume, the onset of nuclear development as shown by the
appearance of the characteristic germinal vesicle and the acquisition
of a zona pellucida. The ﬁrst cohort of follicles to enter the growth
phase in the early post-natal mouse is the most numerous, but still
only represents about 2% of the total number present (Lintern-Moore
and Moore, 1979). It is also interesting to note that in the present
system only one cohort of oocytes, albeit some in each fragment, is
recruited to grow in the explant system. This can be easily seen by the
progressive disappearance of oocytes in the smaller size classes at
days 14 and 21 and the decrease in MVH mRNA and in DNMT1o
nuclear staining at these later stages. Localised signalling after
explanting is also clearly important as growing oocytes also tendedto be clustered in the middle of fragments, suggesting paracrine
stimulatory signalling from granulosa cells.
Primary follicles in our system progressed from unilaminar to
multilaminar, with concomitant decrease in the MVH marker. While
granulosa cells proliferated to form a multilaminar follicle, a complete
squamous thecal layer could not be seen and no antral follicles were
observed. Cells positive for thecal markers such as AP, Cyp17a1 and
Lhcgr were present, but they clearly failed to form a contiguous
layer around the granulosa/oocyte complexes. A mature theca is
crucial to further follicle development for several reasons: the theca
becomes vascularised, allowing delivery of endocrine factors to the
follicle, which starts to become hormone-responsive at around the
time of antrum formation (Hillier, 1994); the vessels are leaky, which
helps to supply ﬂuid for the antrum and ﬁnally the thecal cells
produce androgen using the enzyme 17α hydroxylase (CYP17A1)
which is subsequently converted to estradiol by granulosa cells (van
denHurk and Zhao, 2005). The presence of thecal cells and CYP17A1 in
our in vitro systemmay contribute to oocyte survival after growth has
stopped, since estradiol is a potent anti-apoptotic agent (Knight and
Glister, 2006). Mice disrupted in Gdf9, an oocyte-secreted growth
factor, shows a very similar block in follicle development where a
thecal layer fails to form, despite the presence of thecal cell precursors,
and follicles do not progress to the antral stage (Elvin et al., 1999).
However, in the knockout mice oocytes grew to a much larger size
than seen in vitro and RT-PCR shows that our cultures produce high
levels of GDF9, suggesting that it is not the absence of this factor which
is causing thecal layer failure in this case. It is possible that spatial
constraints on cell movement in the explant system prevent thecal
cells from surrounding the oocytes and that this may be overcome by
using a three-dimensional culturing technique. Supporting this view,
Fig. 6. Activation of DNAmethyltransferase transcription by oocyte growth, not follicle development. (A) Activation of oocyte-speciﬁc promoters for the DNAmethyltransferases. Both
Dnmt1 and Dnmt3L show activation from their oocyte promoters in vitro which parallels that in vivo. SCF appears to increase mRNA levels, particularly at d21. (B) Methyltransferase
levels appear higher in cultures with added SCF. RT-PCR was carried out on RNA from d21 cultures as in panel A, but aliquots removed at the cycle number indicated. Signal appears
ﬁrst in the SCF-treated samples for the methyltransferases, but not for actin. (C) qPCR for Dnmt3Lo. RNA was harvested from untreated (ctrl) and SCF-treated cultures at d21 and
Dnmt3Lo levels analysed by qPCR. (D) Factors which promote oocyte growth appear to lead to increased methyltransferase levels. RT-PCR was carried out on RNA from d21 cultures
treated with the indicated growth factors. (E) Dnmt1 transcription is triggered by oocyte growth in the absence of follicle development. The graph (top) shows average oocyte size in
Foxo −/− ovaries andWT (+/+) controls at the indicated timepoints (redrawn from (Castrillon et al., 2003)). By 14 dpp oocytes in the mutants have grown to twice the normal size but
in the absence of granulosa cell development. Transcript levels for Dnmt1 in Foxo3 mutant vs wild-type post-natal ovaries were compared by microarray (bottom) and found to be
signiﬁcantly elevated. Expression levels in WT adult ovary, isolated eggs and granulosa cells are also shown for comparison. Values represent the mean and SEM for three
experiments: signiﬁcance values are ⁎pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0001, compared to WT. Similar results were found for a second probe (not shown).
Fig. 7. Sequential relocalisation of the methyltransferases in growing oocytes is controlled in part by PI3 kinase signaling. (A) Localisation of the three main enzymes during oocyte
growth in vitro. DNA is stained red with propidium iodide (PI), antibody signal (Ab) is in green and areas of signiﬁcant colocalisation of DNA and antibody indicated in white in the
Merge panel. DNMT1 shows strong signal in the nuclei of oocytes in unilaminar follicles at d7, but is exported to the cytoplasm by day 14, where it is also found at d21. DNMT3A shows
localization to the cytoplasm at d7, but by day 21 signal appears equal in both nucleus and cytoplasm. DNMT3B shows cytoplasmic localization throughout the in vitro culture. (B)
Nuclear export of DNMT1 is blocked by a PI3 kinase inhibitor. LY294002 was added to the oocyte culture medium at d7 and fragments examined at d14. DNA was stained with
Hoescht 33528 and protein with the same antibody as in panel A. In control fragments (top), DNMT1 was found almost exclusively in the cytoplasm, while in cultures grown in the
presence of the inhibitor (bottom), signal was predominantly nuclear.
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Table 1
Summary of methylation analysis for imprinted genes
Gene Control SCF
Samples Methylation Samples Methylation
Snrpn 10 2 6 1
Igf2r 6 3 2 0
Peg1 6 1 n/a n/a
H19 8 0 4 0
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production of follicles enclosed by thecal cell layers which can
subsequently be isolated and cultured separately (O'Brien et al., 2003;
Obata et al., 2002). However, culturing of ovary fragments from post-
natal stages can also be achieved using the system described here and
results in the formation of follicles with thecal cell layers, indicating
that spatial constraints may only be decisive during initial thecal cell
recruitment (Pesce et al., 1996 and data not shown).
SCF is a major enhancer of early oocyte growth
It has previously been shown that SCF on its own can stimulate the
growth of oocytes to about 25 μm and, in the presence of gap junction
contacts with granulosa cells, to about 50 μm (Klinger and De Felici,
2002), after which point oocyte growth becomes SCF-independent.
Our results here reinforce those ﬁndings: SCF stimulated the growth of
the oocytes only up to the end of the second week of culture, after
which point the cultures with this added showed no growth
advantage over the controls. SCF was the major contributor to oocyte
growth of the growth factors tested, but BMP4 and LIF also had
positive effects during early oocyte growth. The loss of dependence on
SCF reﬂects the situation in vivo, where GDF9 secreted by the oocyte
may down-regulate SCF production by the granulosa cells nearest to
the oocyte (Elvin et al., 1999), and the production of GDF9, as well as
the absence of MVH, in the in vitro cultures, reﬂects the maturation of
the oocytes past the initial phase of growth. Although cultures treated
with SCF showed a tendency to have increased mRNA levels for ZP2,
ZP3 and MVH by RT-PCR, absolute levels for ZP3 were not elevated by
qPCR at d21 and so this may simply reﬂect the early-stage cultures
having oocytes of increased size rather than greater numbers.
However, taken together, these results still strongly support a role
for SCF supplementation in oocyte survival and growth.
DNA methyltransferase loading is triggered by oocyte growth and not
follicular development
We show here that the oocyte-speciﬁc promoters of Dnmt3L and
Dnmt1 become activated simultaneously as oocytes enter growth,
suggesting theymay respond to the same transcription factors. Factors
which promote oocyte growth, such as SCF and to a lesser extent
BMP4 and LIF, also promote transcription from these promoters. SCF in
growing oocytes signals in part through the phosphatidylinositol 3
kinase (PI3K) pathway (Liu et al., 2006; Reddy et al., 2005). AKT, a
downstream kinase in this pathway, suppresses the activity of the
transcription factor FOXO3 by causing its phosphorylation and nuclear
export (Brunet et al., 1999). Homozygous deletion of FOXO3, which
regulates the cell cycle and apoptosis, leads to excessive activation of
primordial follicles (Castrillon et al., 2003). This appears to be
independent of granulosa cell growth and differentiation in the
follicle, since oocytes can reach sizes of 50 μM in primordial follicles.
Dnmt1 transcript levels were also elevated in ovaries from Foxo3
mutants, indicating that Dnmt1 is downstream of Foxo3, though not
necessarily a direct target. The activation of Dnmt1 here also indicates
that methyltransferase loading is oocyte-autonomous and does not
require transition to the primary follicle stage.
The in vitro culture system, with its coordinated growth of
relatively large numbers of oocytes and the ease of staining hasfacilitated a closer examination of the accumulation and localisation of
the methyltransferases. DNA methyltransferase localisation is also
clearly an important factor in regulating which enzyme has access to
the genome at any given time. It has been suggested that DNMT1o
might have a role to play in the de novo methylation of IAP elements
(Gaudet et al., 2004): we found however very little evidence of de
novo methylation of IAP in the ﬁrst week of culture when DNMT1o has
access to the chromatin. Our results here support earlier work
showing that DNMT1o has no role to play in establishing imprinting
(Howell et al., 2001), since the protein is conﬁned to the cytoplasm of
oocytes larger than approx 25 μm (bilaminar follicle stage), while
imprints do not appear to be established until the early antral
secondary follicle (N55 μm) (Hiura et al., 2006; Lucifero et al., 2002,
2004; Obata et al., 2002). DNMT3A appears to be conﬁned to the
cytoplasm in small oocytes, but can be detected in both nucleus and
cytoplasm in the largest oocytes late in culture, suggesting that it is
released from cytoplasmic conﬁnement or undergoes active nuclear
transport as follicle development proceeds. DNMT3B localisation is
cytoplasmic in all culture stages examined: in vivo we have previously
found some evidence for nuclear localisation (Lees-Murdock et al.,
2005), so lack of nuclear signal heremay reﬂect the in vitro system not
recapitulating the ﬁnal stages of oocyte growth coincident with
antrum formation. However, disruption of DNMT3B in oocytes has
been reported to have no effect on de novo methylation (Kaneda et al.,
2004), so this is unlikely to account for the lack of de novomethylation
in the current system.
A major part of SCF signalling is thought to occur through the PI3
kinase pathway (reviewed in Liu et al., 2006). Since changes in
phosphorylation and subcellular localisation of FOXO3 are known to be
triggered by PI3 kinase signalling (Brunet et al., 1999; Reddy et al.,
2005), we examined the effects of a PI3 kinase inhibitor on DNMT1o
localisation in our in vitro system.We could show that treatment of the
cultures with inhibitor resulted in a failure to export DNMT1 from the
nucleus. Phosphorylation of FOXO3, which causes its export and the
initiation of oocyte growth (Castrillon et al., 2003), has been shown to
be mediated by AKT (Brunet et al., 1999), since it contains a canonical
RxRxxS/T site, present without exception in all known AKT substrates
(Obata et al., 2000). Although DNMT1 is known to be phosphorylated
on Ser514 (Glickman et al., 1997), this does not conform to the AKT
recognition consensus, nor are any AKT sites present elsewhere in the
amino acid sequence, suggesting that another kinase in the PI3 kinase
pathway may instead be involved. Recent reports from other groups
have also suggested that DNMT1may be a target of the PI3 kinase path
(Hodge et al., 2007; Sun et al., 2007).
Imprint establishment requires development to the secondary follicle
stage for completion and appears to be SCF-independent
We could detect methylation occurring in some of our in vitro
oocyte cultures (approx 15–20%), although we could detect no
differences in average oocyte size or appearance between cultures
showing methylation and those which did not, suggesting small
differences in oocyte environment or explant establishment are
inﬂuencing oocyte maturation and de novo methylation, which is
consistent with the type of variability reported for oocyte cultures by
others (O'Brien et al., 2003; Obata et al., 2002). We found messenger
RNA for Dnmt3Lo and DNMT3A protein to be present in the growing
oocyte of all the cultures that were assayed, and these were found
prior to the establishment of methylation on imprinted genes,
suggesting that de novo methylation cannot be triggered solely by
the presence of the methyltransferases and the cofactor Dnmt3L.
The order in which imprint control regions become methylated in
the oocyte has been established by a number of studies: the maternal
allele of Snrpn is the earliest to be methylated (in oocytes greater than
55 μM in size), followed by Igf2r, then the paternal allele of Snrpn, and
ﬁnally Peg1 (Lucifero et al., 2002; Obata et al., 2002; Lucifero et al.,
Fig. 8. Methylation levels in oocytes grown in vitro. (A) COBRA analysis of imprinted genes. PCR products representing the imprint control regions for the indicated genes were
analysed by digestion with methylation-sensitive enzymes. The sizes of the expected fragments for the unmethylated (u) and methylated (m) alleles are indicated and both are
present in equal amounts in control DNA as expected (adult tail: +), while uncut DNA indicates the size expected for the unmethylated allele (−). Control cultures 1 and 6 show
methylation for Snrpn, while cultures 1, 3 and 4 show some methylation for Igf2r. None show methylation for H19, which is a negative control. Neither of the SCF-treated cultures
(right) which could be analysed for all three genes showed any methylation. (B) Bisulﬁte sequencing of Snrpn. A paired set of control and SCF-treated samples showing some
methylation in the latter only by COBRA (not shown)were analysed by cloning and sequencing. Filled circles represent methylation, open circles nomethylation. Tail DNA is shown as
a control. (C) Bisulﬁte sequencing of Igf2r and Peg1. PCR products from the control cultures indicated in panel Awere cloned and sequenced. Samples showing lowmethylation levels
by COBRA for Igf2r (C2, C6) yielded fewmethylated clones compared to those showing higher levels in the former (C1, C4). (D) IAP clones. IAP elements are present in multiple copies,
with substantial sequence variation. As it proved impossible to isolate oocytes at d1 of culture, female germ cells at e16.5 (equivalent to day1) were used for comparison. (E) Overall
methylation levels in IAP elements. Methylated sites are expressed as a percentage of the total number of sites analysed.
247D.J. Lees-Murdock et al. / Developmental Biology 321 (2008) 238–2502004; Hiura et al., 2006). For those cultures showing methylation, the
same trend was observed, with the genes showing early methylation
(Snrpn and Igf2r) being most frequently methylated, while Peg1,
which is methylated late, showed almost no methylation. This
indicates that methylation is occurring with a similar schedule in
our in vitro system, but even the most methylated samples showed
≤50% methylation of any given gene, indicating that methylation is
incomplete. Our results suggest that the oocytes need to progress to
the secondary follicle stage, with the formation of a complete thecal
layer and antrum, to achieve greater methylation levels. There was no
signiﬁcant difference in the frequency of cultures showing methyla-
tion when samples were grown in the presence of SCF (1/6 with vs 2/
10 without).Two previous reports have also suggested that in vitro growth and
maturation can lead to aberrant methylation of the maternal H19 gene
(Borghol et al., 2006; Kerjean et al., 2003). In our system, we found
that the H19 gene maintains its correct unmethylated status during
oocyte growth.
Evidence for other epigenetic changes occurring at this stage of
development in the female germ cell also exists: the nucleus of the
growing oocyte undergoes step-wise changes in chromatin condensa-
tionwhich culminates in the formation of a surrounded nucleolus (De
La Fuente, 2006; Mattson and Albertini, 1990; Wickramasinghe et al.,
1991). This latter forms just as the antrum appears, marking the
progression to the secondary follicle phase and is coincident with the
shut-down of all transcription. Interestingly, results from other labs
Table 2




Zp1 F 5′-ACCTGAGGGTGTTCATACAAGCC-3′ R
5′-CAGAATCCAGCTCAGTCAATTCC-3′
63 35
Zp2 F 5′-AGAGACAGTATGCTACTAAATGC-3′ R
5′-GGTCGTCAGTACTAAGACCAGCT-3′
63 35






Cyp17a1 F 5′-CGTGGTCATATGCATGCCAAC-3′ R
5′-CCAGGACATCCACAATACCC-3′
58 35
Lhcgr F 5′-CGCTTTCCAAGGGATGAATA-3′ R
5′-AATCGTAATCCCAGCCACTG-3′
58 35
Mvh (Toyooka et al., 2000) 65 25
Sycp3 (Chuma and Nakatsuji, 2001) 65 25
β-actin (Obata and Kono, 2002) 63 25
Dnmt1o F 5′-TTGAGGGTCATTGGAGGAAG-3′ R
5′-GTCTGCCATTTCTGCTCTCC-3′
63 35








β-actin F 5′-TGCGTGACATCAAAGAGAAG-3′ R
5′-CGGATGTCAACGTCACACTT-3′;
55 50
Zp3 F 5′-aagctcaacaaagcctgttcg-3′ R
5′-catcagcttcatcggtcacg-3′
55 50
Dnmt3Lo F 5′-ggcttcctgagaaacaccac-3′ R
5′-gacagcagggtcgtcagaac-3′
54 60
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and deacetylases also accumulate during the primary follicle stage
(Kageyama et al., 2007). Progression to the surrounded nucleolus
stage was not seen either in our in vitro oocytes, conﬁrming the idea
that crucial epigenetic changes are occurring at the point of transition
to the secondary follicle. These results also underline the interplay
between oocytes and their supporting somatic cells and indicate that
de novo methylation does not just rely on an oocyte-intrinsic program
but rather is dependent on outside signals produced by, or mediated
through, the surrounding granulosa and thecal cells.
Materials and methods
Mice
Swiss TO mice were purchased from Harlan UK. Natural matings
were used to produce pregnant females. The day the plug was
observed was taken as e0.5.
Ovary fragment culture in vitro
Pregnant mice were sacriﬁced at e15.5 and embryos collected. The
embryonic ovaries were removed from the abdominal cavity and
placed into M2 medium. The mesonephroi were removed and the
ovaries were sliced into 5–6 transverse sections using two 25 gauge
needles. The ovary fragments were rinsed in two changes of M2
medium and two changes of complete Waymouth medium (Way-
mouth medium supplemented with 0.2 U/ml penicillin/streptomycin
(Pen/Strep), 5% (v/v) fetal bovin serum (FBS), 5% (v/v) horse serum
(HS) and 11 mg/ml sodium pyruvate) before plating up to 30
fragments per 35 mm tissue culture plate (Falcon), each pretreated
with 1 mg/ml ﬁbronectin. The day the culture was set up was counted
as day zero of the culture. Ovary fragments were cultured in complete
Waymouth mediumwhich was changed on day 2 of culture following
adherence of the fragments to the plate, and every 3–4 days thereafter
until day 21 of culture. SCF, LIF or BMP-4was addedwhere indicated to
a ﬁnal concentration of 100 ng/ml: LY294002 (5 μM) was added to
some cultures on day 7.
Oocyte and fragment harvesting
For harvesting, a coarse capillary tube was used to cut around the
margin of an ovary fragment, which was then transferred into a
culture dish with M2 medium. To isolate oocytes, a succession of ﬁnercapillary tubes were used to free the eggs from the fragment by
trituration. Oocytes were transferred several times through M2
medium to remove any debris or somatic cells. The clean oocytes
were snap frozen in liquid nitrogen and stored at −80 °C.
RNA extraction and cDNA synthesis
RNAwas extracted using an RNeasyMini Kit (QIAGEN) according to
the manufacturer's instructions. The concentration of total RNA was
measured using a Nanodrop ND1000 spectrophotometer. Ovary cDNA
was synthesized using Superscript II reverse transcriptase (Invitro-
gen). Brieﬂy, each 20 μl reaction contained 500 ng total RNA, 0.2 μg
Oligo(dT)12–18 primer, 0.5 mM dNTPs, 40 U RnaseOUT, 200 U Super-
script II reverse transcriptase, 1× First-strand buffer and 0.1 M
dithiothreitol (DTT), with reaction conditions as speciﬁed by the
manufacturer.
RT-PCR and microarray
For primers and annealing temperatures, see Table 2. Each 25 μl
reverse transcription reaction contained 0.5 μM of each primer, 3.7 mM
MgCl2 (except 2.5 mM for Gdf9), 0.4 mM dNTPs, 1× PCR buffer, 0.1 U of
Taq polymerase and 1 μl of cDNA. Themixtures were incubated at 94 °C,
3min for initial denaturation, followedby 35 cycles of 30 s at 94 °C,1min
at the annealing temperature (see Table 2) and 1min at 72 °C, and a ﬁnal
elongation at 72 °C for 7 min. Positive (β-actin) and negative (no RT)
reactions were run for all experiments. The microarray experiment was
as previously described (Gallardo et al., 2007).
qPCR
Quantitative PCR (qPCR) was performed by Roche LightCycler® 2.0
using the relative standard curve method with β-actin as the reference
gene. cDNA synthesis was carried out as described above: the cDNAwas
diluted in sdH2O to give 1:10, 1:100 etc and then 3 μl added to each
reaction. Reactionmix usingQiagenQuantiTect® SYBR®Green reagents
was prepared according to the manufacturer's recommendations.
Primers, annealing temperature and total cycle number are given in
Table 3: β-actin primers were as in Steuerwald et al., 2000. The reaction
mixture was incubated at 95 °C, 15 min for activating the HotStar Taq
DNA Polymerase, followed by 50 cycles (β-actin and Zp3) or 60 cycles
(Dnmt3Lo) of 1 s, 20 °C/s, denaturation at 94 °C, 1 s, 20 °C/s to annealing
temperature and 15 s (β-actin andDnmt3Lo) or 10 s (Zp3), 2 °C/s, at 72 °C
for elongation. Speciﬁcity of ampliﬁcation was conﬁrmed by a post-
ampliﬁcation melting curve analysis as recommended by the reagent
manufacturer: this involves heating the sample to 96 °C, cooling to 50 °C
and slowly heating up to 95 °C at 0.1 °C/s to conﬁrm the absence of
subsidiary products.
Chromatin and antibody staining and visualisation of cultured ovary
fragments
Antibody staining was carried out essentially as in Lees-Murdock
et al., 2005. For chromatin staining, cultured ovary fragments were
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5 min in PBS and stained with Hoechst 33528 (1 mg/ml) for 15 min
followed by 3 washes in PBS. Stained slides were mounted in
Vectashield Mounting Medium (Vector Labs). Images were captured
using a Leica TCS SP5 multiphoton microscope (Leica Microsystems
CMS GmBH) and colocalisation determined using NIH ImageJ and the
colocalisation plug-in (courtesy of Pierre Bourdoncle).
Alkaline phosphatase staining of ovary sections and cultured ovary
fragments
Ovary cultures were ﬁxed in 4% ice-cold paraformaldehyde. 1 mg/
ml napthol AS-MX (Sigma) was prepared from10mg/ml stock napthol
in N,N-dimethylformamide (DMF) by dilutionwith Tris buffer (pH 9.2)
and 4 mg/ml fast red TR salt (Sigma) was added to the mixture.
Specimens were incubated in the solution for 15 min and washed 3
times 5 min in PBS. Stained samples were mounted in 50% glycerol-
PBS. Images were captured using a DS-5M-L1 Digital Sight Camera
System (Nikon).
Statistical analysis
Results are presented as mean±standard deviation (oocyte growth
in vitro) or standard error of the mean (microarray) as indicated in the
ﬁgure legend. Datawas analysed using unpaired Student's t-tests with
INSTAT software. Differences were considered signiﬁcant if pb0.05.
Bisulﬁte treatment
Bisulﬁte treatment was carried out using a direct analysis
method (Warnecke et al., 1998). To the tube containing the isolated
oocytes, 2 μg/ml tRNA, 1 mM SDS, 2 mg/ml proteinase K was added
and the volume adjusted to 40 μl with dH2O. The mixture was
overlaid with mineral oil and incubated at 37 °C for 1 h. Then
samples were either processed using the Qiagen Epitect kit
according to the manufacturer's recommendations or analysed
manually. For the latter, proteinase K was inactivated by heating
at 95 °C for 15 min and NaOH added to a ﬁnal concentration of
0.32 M and incubated at 37 °C for 15 min. Bisulﬁte conversion was
performed by adding tRNA to a ﬁnal concentration of 2 μg/ml with
0.5 M hydroquinone and 3.1 M sodium bisulﬁte and incubated at
50 °C for a minimum of 3 h. DNA was then cleaned using the
Promega Wizard kit and eluted in a volume of 100 μl dH2O.
Conversion was completed by incubation at 37 °C with 0.3 M NaOH
for 15 min. DNA was precipitated at −20 °C overnight by addition of
2 μg/ml tRNA, 0.5 M ammonium acetate and 67% ethanol. Nucleic
acid was pelleted by centrifugation, washed with 80% cold ethanol
and resuspended in 13 μl TE8 and 1 μl (IAP) or 5 μl (single-copy genes)
used for PCR. For the Qiagen kit, samples were eluted in 40 μl elution
buffer and 2–8 μl used for PCR.
PCR ampliﬁcation of bisulﬁte-treated DNA
PCR reactions for Snrpn and IAPs were carried out on bisulﬁte-
treated DNA using primers speciﬁcally designed for converted DNA as
previously described (Li et al., 2004; Lane et al., 2003). For the single-
copy genes two rounds of PCR were carried out with nested primers. A
50 μl reaction contained 5 mM (Snrpn, Peg1, H19) or 2.5 mM (Igf2r)
MgCl2, 1× buffer, 0.4 mM dNTPs, 1 pmol of each primer and 2 U of Taq
DNA polymerase (Promega). For the second round of PCR 2 μl of the
ﬁrst round sample was added to fresh reaction mix. One round of PCR
was sufﬁcient for ampliﬁcation of IAP sequences, with conditions
identical except the MgCl2 concentration was 3.5 mM. Cycling
conditions for all reactions were denaturation for 5 min at 94 °C,
followed by 35 cycles of 30 s denaturation at 94 °C, 1 min at 55 °C, and
1 min at 72 °C and a ﬁnal 7 min elongation step.Cloning and DNA Sequencing
PCR products were excised from agarose gels following resolution
and puriﬁed using the Qiaquick gel extraction kit (Qiagen) or the
Wizard kit (Promega). The DNA was subcloned into the pTOPO TA
vector (Invitrogen) and transformed into One Shot chemically
competent cells (Invitrogen). Colonies were selected and plasmids
were extracted by Qiaprep Spin Miniprep Kit (Qiagen). Cycle
sequencing reactions were carried out using the BigDye terminator
v3.1 cycle sequencing kit according to the manufacturer's instructions
(Applied Biosystems). Each 10 μl reaction contained 5 μl miniprep
product, 0.32 μM M13 reverse primer (5′-CAGGAAACAGCTATGAC-3′)
and 4 μl Big Dye Ready ReactionMix. Conditions were as follows: 96 °C
initial denaturation for 1 min followed by 25 cycles of 30 s at 96 °C,
30 s at 50 °C and 4 min at 55 °C. Products were analysed on an Applied
Biosystem 3100 Genetic Analyser.
COBRA assay
Approximately 100 ng of gel puriﬁed PCR products were digested
with BstUI (Snrpn, Igf2r) or TaqI (H19) (both New England Biolabs),
both of which will only digest sequences which were originally
methylated. Resultant reactions were analysed by 3% agarose gel
electrophoresis.
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